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E) in brain. In this investigation, the patterns of depletion of alpha tocopherol from tissues of apoE deﬁcient
and wild type mice were compared after the animals were fed vitamin E deﬁcient diets. Alpha tocopherol
concentrations in speciﬁc regions of the brain and peripheral tissues at different times were determined by
HPLC with electrochemical detection. ApoE deﬁciency signiﬁcantly retarded the rate of depletion of alpha
tocopherol from all regions of the brain. In addition, comparison of the rates of depletion of alpha tocopherol
in both apoE deﬁcient and wild type animals showed that cerebellum behaved differently from other areas
such as cortex, hippocampus and striatum. This reinforces the uniqueness of cerebellum with regard to
vitamin E biology. Patterns of depletion of tocopherol from peripheral tissues were different from brain.
Serum tocopherol was higher in apoE deﬁcient animals and remained higher than wild type during E
deﬁciency. Depletion of liver tocopherol also tended to be unaffected by apoE deﬁciency. Our current and
previous observations strongly suggest that apoE has an important role in modulating tocopherol
concentrations in brain, probably acting in concert with other proteins as well.






Many experimental and clinical reports indicate that vitamin E has
an impact upon the incidence and treatment of Alzheimer's disease
(AD) even though some aspects have been somewhat controversial.
Behl et al. [1] have found that vitamin E in the culture medium
protected PC12 cells (that are used as models of peripheral neurons)
from the cytotoxic effects of amyloid beta protein. A study on
experimental animals also tends to support a role for vitamin E in
altering learning behavior. Ichitani et al.[2] found that vitamin E had
an effect on a step-through passive avoidance response task and found
that the vitamin E deﬁcient animals showed signiﬁcantly lower and
vitamin E supplemented animals signiﬁcantly higher rates of passive
avoidance response than the control animals. Investigations con-
ducted at Chicago, USA [3] and Rotterdam, Netherlands [4] suggest
that higher intakes of antioxidants, especially vitamin E, are associated
with a lower risk of incidence of AD. However, a randomized trial of
dietary supplementation of vitamin E did not ﬁnd any beneﬁcial
effects on cognitive function in healthy older women [5]. In a
controlled clinical trial in humans Sano et al.[6] showed that vitamin
E treatment slows the progression of AD. It should be noted, however,edical Center, Minneapolis, MN
.
.V.that a recent review examining the clinical use of vitamin E in AD
could only conclude that this practice “may be” of some beneﬁt [7].
Thus there is need for additional information on the potential
relationships between vitamin E and other factors that may inﬂuence
cognition.
Numerous studies have shown that apolipoprotein E (apoE) has an
important role in the pathophysiology of AD. Genetically, the presence
of the apo E4 allele is associated with the late-onset, sporadic form of
AD [8]. This observation has led to a large number of studies on the
functions of apoE in brain. Some of the neuropathological features of
AD that have been replicated in transgenic mice overexpressing apo
E4 gene include reduced numbers of presynaptic terminals, increased
plaque deposition, increased phosphorylation of tau, and impaired
learning and memory (see review [9]). Even though most investiga-
tions deal with the impact of apoE on lipid metabolism in peripheral
tissues, apoE also plays an important role in lipid metabolism in brain.
Studies indicate that apoE mediates sulfatide trafﬁcking and metabo-
lism in the CNS, alters phospholipid molecular species in some
membranes, and inﬂuences cholesterol dynamics (see review [10]).
We have observed that there is biological interaction between
vitamin E and apoE. Firstly, the steady state levels of alpha tocopherol
in different brain regions were lower in apoE deﬁcient mice compared
with the wild type [11]. The changes in tocopherol concentrationwere
dependent upon age and were also speciﬁc for different regions of the
brain. Secondly, we observed that when radioactive vitamin E was
Fig. 2. Alpha tocopherol concentrations in the hippocampus of wild type and apoE
deﬁcient mice fed vitamin E deﬁcient diets. The tissues were dissected out as described
and tocopherol concentrations determined by HPLC with electrochemical detection.
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activity by different brain regions of apoE deﬁcient animals were
different from that of the wild type brain [12]. The focus of the current
investigation is to compare the rates of depletion of vitamin E from
different brain areas of apoE deﬁcient and wild type animals on
vitamin E deﬁcient diets.
2. Materials and methods
2.1. Chemicals
The chemicals used were of reagent grade purity from standard sources. Solvents
for chromatography were HPLC grade from Fisher Scientiﬁc, Itasca, IL., U.S.A. Standard
alpha tocopherol was purchased from Kodak Laboratory Chemicals, Rochester, NY, USA.
Absolute ethanol was obtained from Aaper Alcohol and Chemical Company, Shelbyville,
Kentucky, U.S.A., and was redistilled prior to use. Most of the other reagent grade
chemicals were from Sigma Chemicals, St. Louis, MO, USA.
2.2. Treatment of animals
All procedures with animals were approved by the Subcommittee on Animal
Studies of the Minneapolis Veterans Affairs Medical Center. Mice with the Apoe gene
knocked out (C57BL/6J-Apoetm1/unc) were obtained commercially from Jackson
Laboratories, Bar Harbor, Maine. Control mice (C57 BL/6J) were also purchased from
the same source. The animals obtained after weaning were placed on control or vitamin
E deﬁcient diet for a period of 9.5 months. The diets were custom manufactured by
Dyets Inc., Bethlehem, PA 18017 (catalog numbers 119614 and 119615) according to the
speciﬁcations of AIN 93 puriﬁed diets for laboratory rodents [13] and slightly modiﬁed
for production of vitamin E deﬁcient formulations. The lipid source was tocopherol-
stripped lard (10%). The control diet was obtained by the addition of 75 IU of vitamin E
as alpha tocopherol acetate per kg diet.
After different times on the control or vitamin E deﬁcient diet the animals were
anesthetized and perfused with cold isotonic saline via a catheter inserted into the left
cardiac ventricle. The brain was then taken out and lightly rinsed with cold isotonic
saline. The different brain regions were dissected out according to the method of
Glowinski and Iversen [14]. The tissues were weighed, homogenized in 0.32 M sucrose,
10 mM HEPES, 1 mM EDTA at pH 7.4 and stored at −70 °C and were used later for the
various assays.
2.3. Determination of tocopherol
The method for determination of tocopherols by liquid chromatography has been
published [15]. Brieﬂy, 2 ml ethanol containing 0.025% (w/v) butylated hydroxytoluene
(BHT) and 0.1ml of 30% (w/v) ascorbic acid were pipetted into tubes containing samples
for tocopherol analyses. The mixture was saponiﬁed at 60 °C for 30 min after the
addition of 1 ml of 10% potassium hydroxide solution. Sample tubes were cooled and
2 ml of water was added followed by 2 ml of hexane containing 0.025% (w/v) BHT.
Tocopherols were extracted into the hexane phase by vortexing the samples for 1 min.
The hexane phase was separated out and evaporated down under a stream of nitrogen.
The residue was redissolved in mobile phase and analyzed by reverse phase liquid
chromatography using the following conditions: column=ultrasphere ODS, 5 μm,Fig. 1. Rates of decline of alpha tocopherol in cerebellum of apoE deﬁcient and wild type
mice that were fed vitamin E deﬁcient diet for 9.5 months. At the indicated times the
animals were sacriﬁced, perfused with cold isotonic saline, and tissues were dissected
out. Alpha tocopherol concentrations were determined in the tissue samples by HPLC
with electrochemical detection using procedures described. Each point represents
mean of values obtained from four different animals in this and the rest of the ﬁgures.
Error bars are S.E.M.4.6×150 mm (Beckman Instruments, Fullerton, CA, USA); mobile phase=methanol :
water, (94.5 : 5.5) with 7.5 mM sodium dihydrogen phosphate (ﬁnal concentration);
ﬂow rate=2.7 ml/min. The tocopherols were detected electrochemically: Coulochem
5100 A detector, 5011 analytical cell with detector 1 at −0.25 V and detector 2 at +0.65 V
and 5021 conditioning cell at −0.75 V.
2.4. Other biochemical assays
Concentration of total protein was determined by the Lowry technique as modiﬁed
by Markwell et al [16].
2.5. Statistical methods
SPSS (version 15, Chicago, Illinois) was used to determine multiple regressions as
estimates of the linear and curvilinear effects of the duration of dietary regimen upon
alpha tocopherol concentrations in tissue. In addition, standard ANOVA as well as
student t-tests were also used as indicated.
3. Results
Data from our lab and those of other investigators have shown that
the characteristics of handling of tocopherols are different among
various regions of thebrain. For example, cerebellum is an area of special
interest with regard to the metabolism and utilization of vitamin E.
Hencewedetermined the changes in concentrationsof alpha tocopherol
in different brain regions such as cerebellum, hippocampus, cerebral
cortex and others. Fig.1 shows the rate of decline of alpha tocopherol in
the cerebella of apoE deﬁcient and wild type animals.
As we have reported before [11], cerebellar alpha tocopherol levels
are lower in the apoE deﬁcient animals than the wild type at the
beginning of the dietary regimen. However, vitamin E deﬁciency
results in a sharper decline in tocopherol levels in the wild type
animals. At the end of the study the apoE deﬁcient animals have
slightly higher levels of alpha tocopherol in cerebellum than the wild
type. Alpha tocopherol concentration as a function of time on the
vitamin E deﬁcient diet was subjected to statistical analysis. The data
showed signiﬁcant curvilinear effect with R2 of 0.964. The curvilinear
interaction term (group×time2) was highly signiﬁcant indicating that
the two groups (wild type and apoE deﬁcient) were signiﬁcantly
different with regard to the patterns of decline of alpha tocopherol
levels over time (Pb0.001). In general, the rate of decline of vitamin E
was slower in the apoE deﬁcient than in the wild type animals.
Next,weexamineddata fromhippocampus, anarea thatplaysa critical
role in memory function. The results would be useful for understanding
the potential importance of tocopherols in disorders of memory such as
Alzheimer's disease. The declines in alpha tocopherol levels as a function
of the duration of vitamin E deﬁciency are shown in Fig. 2.
Hippocampal alpha tocopherol levels were lower in the apoE
deﬁcient animals at the beginning of the study, as we reported earlier.
Fig. 3. Changes in alpha tocopherol concentrations in two brain regions of wild type and
apoE deﬁcient mice that were fed normal rodent diets. A. Cerebellum and B. Hippo-
campus. Dietary treatment of the mice were identical to the vitamin E deﬁcient study
except for the addition of normal levels of vitamin E.
416 G.T. Vatassery et al. / Biochimica et Biophysica Acta 1782 (2008) 414–420Furthermore, the rate of decline of alpha tocopherol concentration
was slower in apoE deﬁcient animals compared to the wild type. As
observed with cerebellum, the curvilinear group interaction termwas
signiﬁcant (Pb0.001). Thus, the rate of decline of alpha tocopherolFig. 4. Alpha tocopherol concentrations in sera of wild type and apoE deﬁcient mice that wer
sera obtained after centrifugation of clotted blood. Alpha tocopherol concentrations were ass
indicated by the arrow within the Figure along with a different Y-axis. Statistical comparisofrom the hippocampus of apoE deﬁcient mice was also signiﬁcantly
slower than that of the wild type animals.
In order to calculate thehalf lives for alpha tocopherol depletion from
the cerebellum and hippocampus the alpha tocopherol concentrations
were converted to logarithmic values and ﬁtted to linear equations.
Using these equations the calculated half lives for tocopherol depletion
were as follows. a) Cerebellum: wild type=2.91 months; apoE deﬁ-
cient=6.86 months. b) Hippocampus: wild type=4.24 months; apoE
deﬁcient=11.6 months. The half lives for tocopherol were increased by
2.36-fold in the cerebellum and 2.74-fold in the hippocampus of the
apoE deﬁcient animals when compared with the wild type conﬁrming
that apoE deﬁciency results in slowing of tocopherol turnover in the
brain. It is also interesting to note that Burton et al. [17] calculated the
half lives of deuterium labeled alpha tocopherol in various tissues and
reported that thehalf lives of the compound in brain are 107 and 40days
in guinea pigs and rat, respectively. These values are comparable to the
half lives in the wild type animals in the current study.
Since this study involved feeding of mice with vitamin E deﬁcient
diets for considerable lengths of time it is important to examine
whether there are any changes in brain alpha tocopherol concentra-
tions when mice are fed normal diets for the same length of time.
Therefore, mice were fed normal diets and brain samples were
removed as described under Materials and methods and the tissues
analyzed for alpha tocopherol by HPLC. The results for cerebellum and
hippocampus are shown in Fig. 3A and B. The ﬁgures show that the
alpha tocopherol concentrations in both brain regions increase during
the course of the experiment when the animals were fed normal diets
irrespective of the apoE deﬁciency status.
We examined the depletion of alpha tocopherol from several other
regions of the brain such as pons, hypothalamus, midbrain, and cortex
of mice fed vitamin E deﬁcient diets. Statistical examination of data
from all these regions showed that the two groups (apoE deﬁcient and
wild type)were signiﬁcantly differentwith regard to the rates of decline
in alpha tocopherol when the animals were fed vitamin E deﬁcient
diets. The patterns of decline in alpha tocopherol levels were nearly
identical in all cases suggesting that the underlying mechanism(s) re-
sponsible for the differences in the rates of depletion of alpha
tocopherol were the same in all cases.
A few selected peripheral tissues were also analyzed. It should be
emphasized that the initial levels of alpha tocopherol in peripheral
tissues are not lower in the apoE deﬁcient animals compared with
wild type, unlike brain concentrations. Alterations in serum concen-
trations are of special interest since tocopherols have to be
transported to the brain via serum. The data are shown in Fig. 4.e fed vitamin E deﬁcient diets. Blood samples were collected at the time of sacriﬁce and
ayed by HPLC. Note that the concentrations at 2.5 and 6 months are very low and this is
ns: P values ⁎⁎b0.01; ⁎b0.03.
Fig. 6. Comparison of the rates of loss of alpha tocopherol from four regions of the brains
of wild type and apoE deﬁcient animals that were fed vitamin E deﬁcient diets. The
alpha tocopherol concentrations are expressed as percent of the initial values. A) Wild
type B) ApoE deﬁcient.
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concentrations undergo very steep declines such that the levels are
below limits of measurement at 9.5 months and hence data are shown
only until six months of feeding of vitamin E deﬁcient diets. In sharp
contrast with brain, tocopherol was depleted dramatically in serum
evenwithin two and half months of deﬁciency. The data are shown as
bar graphs with concentration values after 2.5 and 6.5 months of
vitamin E deﬁciency being depicted on a separate Y-axis. It is note-
worthy that the serum alpha tocopherol concentrations were
signiﬁcantly higher in the apoE deﬁcient animals at the beginning of
the study when compared with wild type animals. This relationship
was maintained throughout the study. Thus, apoE deﬁciency did not
alter the mode of depletion of alpha tocopherol in serum, in sharp
contrast to brain.
Liver plays a critically important role in the metabolism and
processing of tocopherols [18]. Hence changes in alpha tocopherol
levels in livers of both types of mice raised on vitamin E deﬁcient diets
are of special interest. The data from this experiment are shown in Fig. 5.
Liver alpha tocopherol concentrations at the start and after
2.5 months of dietary treatment tended to be higher in the apoE
deﬁcient animals than inwild type. This effect is similar to that observed
in the serum and opposite of that in brain. However, the alpha
tocopherol levels in the apoE deﬁcient liver were not signiﬁcantly
different from that of wild type animals throughout the study. The
contrast in the rates of tocopherol depletion within the brain and liver
(for example, compare Figs.1 and 5) suggests that apoEmay be involved
speciﬁcally in the uptake and handling of tocopherol within brain cells
such as neurons and glia.
We have reported that the patterns of change in alpha tocopherol
concentrations with age in the apoE deﬁcient animals were different
among speciﬁc regions of the brain [11]. In addition, we have reported
earlier that the rate of decline of alpha tocopherol from the cerebellum
ofmice is strikingly different from those of other areas of the brain [19].
Both of these reports demonstrate that vitamin E processing in the
cerebellum has some unique features. Therefore, we compared the
declines in alpha tocopherol concentrations in cerebellum with those
from other brain regions as a function of the duration of vitamin E
deﬁciency. The results fromdifferent brain regions are shown in Fig. 6A
and B with changes graphed as percent of original value.
It can be seen that the data formed two regional groups consisting
of cerebellum at the bottom and cerebral cortex, hippocampus and
striatumas a separate group at the top. The two groupswere compared
using matched pair t-tests and were found to be signiﬁcantly different
(Pb0.01at each time point for both wild type and apoE deﬁcientFig. 5. Alpha tocopherol concentration in liver of wild type and apoE deﬁcient mice fed vitam
by HPLC with electrochemical detection as detailed under Materials and methods. Note that
within the Figure along with a different Y-axis.animals). Thus, cerebellum exhibits a different rate of tocopherol
depletion compared with cortex, hippocampus and striatum. This is
very similar to our observation in an earlier study where the animals
were on normal diet and the changes in alpha tocopherol at differentin E deﬁcient diets. The liver samples were collected and analyzed for alpha tocopherol
the concentrations at 2.5 and 6 months are very low and this is indicated by the arrow
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point to differences in the mechanism and/or rate of handling of
tocopherol in different regions of the brain. Cerebellum tends to be
unique in this and other functional parameters related to tocopherol
handling and metabolism (see Discussion).
4. Discussion
4.1. Accumulation of alpha tocopherol in the cerebellum and hippocampus
of wild type and apoE deﬁcient mice placed on normal diets
We observed that alpha tocopherol concentrations increased in
brain regionswhenmicewere fed normal diets over the same length of
time as the vitamin E deﬁciency study (Fig. 3A and B). Our data (Fig. 3A)
also show that alpha tocopherol concentration in the cerebellum of
apoE deﬁcient animals became equal to the wild type at the oldest age
studied. Thus the changes in alpha tocopherol levels with age when
mice were fed normal diets were dependent upon the anatomic site
and this has already been discussed in detail [11]. It can also be noted
that the observed increase in alpha tocopherol with age agrees with
the data from Ramassamy et al [20]. In any case, the dynamics of the
rate of depletion of alpha tocopherol after vitamin E deﬁciency seem to
differ from the rate of increase of the compound when animals were
fed normal diet in that the patterns of increase in alpha tocopherol
levels are similar in both wild type and apoE deﬁcient animals.
4.2. Overview of the main ﬁnding of the vitamin E deﬁciency study
One of our main ﬁndings is that the rates of decline of alpha
tocopherol in brain regions of apoE deﬁcient animals are slower
compared with those from brains of wild type animals when both
groups were fed vitamin E deﬁcient diets. ApoE deﬁciency results in
slower rates of processing of vitamin E within brain. Such slower rates
could result from simple retardation of removal of tocopherol and/or
decline in rate of utilization of tocopherol. The modes of transport of
alpha tocopherol between brain cells and extracellular ﬂuid will
determine the rate of depletion of brain tocopherol.
Information on proteins that can be involved in the transport and
processing of tocopherol within brain can be derived from studies of
lipoproteins in cerebrospinal ﬂuid which exist in equilibriumwith brain
extracellularﬂuid. ApoE is the primary lipoprotein in cerebrospinalﬂuid
and therefore this molecule could have a critical role in lipoprotein-
mediated transport. In addition, it is known thatHDL enriched in apoE is
a predominant lipoprotein in CSF [21,22]. Reports also show that alpha
tocopherol bound to HDL is transferred to pneumocytes [23] and brain
capillary endothelial cells [24], It is possible that tocopherol transport
between cells in thebrain ismediatedbyapathway facilitatedbyapoE in
HDL. Such apathwaywouldnot beoperatingefﬁciently in apoEdeﬁcient
animals. An alternate explanation for the slower movement of
tocopherol in the apoE deﬁcient animals is that other molecules that
normally participate in the cellular uptake of alpha tocopherolmay have
been altered in concentration, composition or structure in response to
apoE deﬁciency.
4.3. Cellular uptake and transport of tocopherol in brain: possible
importance of proteins other than apoE
Both VLDL and LDL are important in the delivery of tocopherol to
extrahepatic tissues. The process involves the LDL-receptor mediated
pathway as well as an independent pathway utilizing lipoprotein
lipase or phospholipids transfer protein (see review Hacquebard and
Carpentier [25]). It has been suggested that tocopherol uptake could
involve the binding of HDL particles (containing alpha tocopherol) to
the SR-BI receptor followed by the entry of tocopherol into cells [26].
Interestingly, a deﬁciency of SR-BI receptor led to declines in
tocopherol levels in various tissues including brain [27]. Studies byKostner et.al. [28] have shown that phospholipid transfer protein from
lipoprotein-free plasma can also facilitate transfer of tocopherol from
lipoproteins to cells. Lipoprotein lipase should also be considered.When
lipoprotein lipase was overexpressed speciﬁcally in muscle, concentra-
tions of tocopherol increased in this tissue whereas no changes in
tocopherol levels were observed in the brain where lipase levels were
unaltered [29]. Another protein of interest is afamin which is a
glycoprotein with a large binding capacity and multiple binding sites
for both alpha and gamma tocopherol. Afamin occurs in signiﬁcant
amounts in both blood plasma and cerebrospinal ﬂuid and may play a
role in transporting tocopherol to the brain [30,31]. The relative
importance of apoE when compared with the above proteins as a
mediator of alpha tocopherol transport needs further investigation.
4.4. Depletion of tocopherol from liver
ApoE deﬁciency did not have a signiﬁcant impact upon liver
concentrations of alpha tocopherol since the decline in liver vitamin E
upon treatment with vitamin E deﬁcient diets was not affected by
apoE deﬁciency (Fig. 5). ApoE has well-known functions in the
binding, uptake and catabolism of lipoproteins. Hence, one would
expect apoE to have a signiﬁcant impact upon lipoprotein metabolism
and transport of lipids in general. Furthermore, liver is critical for the
handling of vitamin E [18]. Alpha tocopherol transfer protein plays a
very important role in loading of VLDL with tocopherol in the liver for
transport to other tissues (see review [26]). Liver is also important for
the metabolism of vitamin E via the cytochrome P450 system [32].
These and other unknown proteins may have dominant effects on the
dynamics of alpha tocopherol in liver with apoE playing a much less
crucial role in this organ. This may explain the relative lack of effect of
apoE deﬁciency on liver concentrations of alpha tocopherol.
4.5. Depletion of serum tocopherol
Our data show that apoE deﬁcient animals have very high levels of
serum alpha tocopherol and the latter was depleted quite fast in both
wild type and apoE deﬁcient animals (Fig. 4). The serum depletion
pattern is different from that of the brainwith serum alpha tocopherol
remaining high in apoE deﬁcient animals compared to wild type
throughout the study (Compare Figs. 1 and 4). A number of proteins
such as lipoprotein lipase and PLTP may be involved in the transport
and uptake of tocopherol in serum and peripheral tissues [33]. Thus,
apoEmay only be playing a minor role in controlling tocopherol levels
in serum.
4.6. Neuroanatomical considerations and the uniqueness of cerebellum
Our data show that the rates of depletion of alpha tocopherol from
the cerebellum are signiﬁcantly faster than those from cortex,
hippocampus and striatum (Fig. 6). In our previous study the rates of
accumulation of alpha tocopherol with age also showed the same
grouping of the different brain regionswith cerebellumbeing different
from the others [11]. The current data reinforces the conclusion that
cerebellum is unique with regard to processing of alpha tocopherol.
4.7. Mechanistic considerations
We do not have sufﬁcient information to propose a deﬁnitive
mechanism for the modulation of brain tocopherol dynamics by apoE.
However, some speculations can be entertained. Our published data
show that the steady state levels of alpha tocopherol in nearly all brain
regions of apoE deﬁcient mice are lower that those in the wild type
[11]. A biological interaction between apoE and vitamin E is also
reinforced by other lines of evidence showing that oxidative damage
in the central nervous system of apoE deﬁcient animals is modulated
by dietary administration of vitamin E [34] or by the combined dietary
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found that the half life of tocopherol is slower in the apoE deﬁcient
mice. Nonetheless, it should be noted that alpha tocopherol
concentrations in the brains of apoE deﬁcient animals are at least
40% of wild type levels [11] suggesting that other proteins are also
involved in tocopherol handling in the brain. Our current hypothesis is
that apoE along with one or more other proteins is involved in the
trafﬁcking of tocopherol in the brain. Many molecules or lipoproteins
can be suitable as apoE partners. Some of these proteins have already
been discussed. Alpha tocopherol transfer protein has been the object
of many investigations on tocopherol dynamics. However, we feel that
alpha tocopherol transfer protein may not play a major role in this
process since we and others have not observed signiﬁcant levels of
this protein in the brain [36,37] even though speciﬁc cell types contain
alpha tocopherol transfer protein that can be demonstrated by
immunohistochemical methods [38]. Nonetheless, a recent study by
Yoshida et al. [39] using mice deﬁcient in both apoE and alpha
tocopherol transfer protein genes found that vitamin E modulates
oxidative stressmarkers in this model indicating a possible interaction
between apoE and alpha tocopherol transfer protein. Hence the
involvement of the latter protein in tocopherol trafﬁcking in brain
should be left open for further studies. As mentioned earlier, other
species such as lipoprotein lipase, scavenger receptor SR-BI and HDL
are worthy of experimental investigations (see review by Mardones
[26]) as potential partners in a complex with apoE that may facilitate
the movement of alpha tocopherol between neurons and glia.
4.8. Impact of our ﬁndings for the therapeutic use of vitamin E
The observed interaction between vitamin E and apoE can be
postulated to have at least two possible consequences. A). The clinical
efﬁcacy of vitamin E may depend upon the level of biological activity
of apoE which in turn can be modulated by apoE molecular structure
and environmental factors. Support for this idea comes from a number
of studies. The fact that serum cholesterol is different among carriers
of apolipoprotein E2, E3 and E4 genes is themost established property
of apoE. Interestingly, Ortega et al. [40] found that alpha tocopherol
levels in each plasma lipid class vary according to apoE genotype
suggesting an analogous inﬂuence of apoE genotype upon serum
alpha tocopherol. In addition, dietary or environmental factors could
also play important roles. For example, Corella et al. [41] observed that
the effect of alcohol intake on LDL cholesterol was inﬂuenced by apoE
polymorphism. B). Vitamin Emay have efﬁcacy only in the presence of
speciﬁc disease-related pathology. Studies of the effectiveness of
drugs as a function of apoE isoforms support this idea. For instance,
carriers of apo E2 were found to be more responsive to statins than
those carrying E3 or E4 [42]. Another investigation demonstrated that
qualitatively the response of subjects with Alzheimer's disease to the
cholinesterase drug rivastigmine was different among E4 carriers
compared with others [43]. In short, factors that inﬂuence the
biological function of apoE such as presence of speciﬁc isoforms as
well as environmental factors and the disease process would be
expected tomodulate the interaction between apoE and vitamin E and
in turn inﬂuence the clinical efﬁcacy of vitamin E.
4.9. Conclusions
Our investigation shows that apoE deﬁciency retards the depletion
of alpha tocopherol from different regions of mouse brain. The
characteristics of depletion of brain tocopherol are very different from
those in peripheral tissues like liver where the depletion of tocopherol
was not modulated by apoE deﬁciency. This could be due to the
function of other proteins (such as tocopherol transfer protein) that
may play dominant roles in tocopherol processing within the liver and
not in the brain. Tocopherol dynamics in the serum compartment is
quite different since apoE deﬁciency alone results in substantialincrease in serum alpha tocopherol concentrations. In this case also
other proteins such as phospholipid transfer protein and afamin may
have dominant roles in maintaining serum alpha tocopherol concen-
trations. The data presented here, along with our previous reports,
suggest that apoE is an important protein taking part in alpha
tocopherol processing within brain. It is quite likely that a complex of
apoE with other proteins may be involved in this process.
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